Description de l'entreprise
STRATEC SE designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers integrated laboratory software and complex consumables for diagnostic and medical applications. STRATEC covers the entire value chain - from development to design and production through to quality assurance. The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of its own patented technologies. Shares in the company are traded in the Prime Standard segment of the Frankfurt Stock Exchange.
Conseil d'administration & Conseil de surveillance
| PDG |
| Marcus Wolfinger |
| Conseil d'administration |
| Dr. Claus Vielsack, Dr. Robert Siegle, Dr. Georg Bauer |
| Conseil de surveillance |
| Prof. Dr. Georg Heni, Dr. Frank Hiller, Dr. Rolf Vornhagen, Dr. Patricia Geller |
Données de l'entreprise
| Nom: |
STRATEC SE |
| Adresse: |
Gewerbestraße 37,D-75217 Birkenfeld |
| Téléphone: |
+49-7082-7916-0 |
| Fax: |
+49-7082-7916-999 |
| Courriel: |
info@stratec.com
|
| Internet: |
www.stratec.com |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
35.57% |
| IPO date: |
25/08/1998 |
Relations avec les investisseurs
| Nom: |
Jan Keppeler |
| Téléphone IR: |
+49-7082-7916-991 |
| IR-Fax: |
+49-7082-7916-9190 |
| E-mail IR: |
ir@stratec.com
|
